Study reveals that the successful downstaging of advanced HCC via locoregional therapy prior to transplant yields 5-year survival rate of 60 percent. Two liver experts explain the impact on patients and the transplant community.
Cleveland Clinic surgeons used a new transplant protocol to treat a patient with liver metastases from colorectal cancer for the first time in the U.S. Learn how this protocol could improve patient outcomes.
HALT-HCC is practical, easy to implement and outperformed other selection criteria. It has the potential to become a new clinical tool that can lead to more efficient use of donated organs.
Denied surgery elsewhere, a 77-year-old undergoes a complex liver resection for hepatocellular carcinoma with outstanding results.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Cleveland Clinic Liver Tumor Clinic’s Federico Aucejo, MD, discusses how a regional-directed chemotherapy option is providing hope for patients with non-resectable colorectal cancer with liver metastases.
A new treatment option for an aggressive cancer — Cleveland Clinic offers liver transplant for hilar cholangiocarcinoma. Liver replacement offers 70 to 80 percent chance of cure to select patients.
Cleveland Clinic’s Liver Tumor Clinic provides leading-edge, individualized treatment of complex liver cancer in an innovative multidisciplinary model clinic.